Ibom Air Targets Vulnerable Groups With 50,000 Anti-Malaria Doses

Ibom Air has donated 50,000 doses of anti-malaria medications to the Akwa Ibom State Ministry of Health as part of efforts to reduce the disease burden among children and pregnant women in vulnerable communities.

The donation, presented on April 24, 2026, includes 30,000 doses of Sulfadoxine-Pyrimethamine, 10,000 doses of Lokmal DT, and 10,000 doses of Paracetamol DT. The airline’s Chief Executive Officer, George Uriesi, led the presentation alongside members of the management team.

The drugs were received by the Akwa Ibom State Commissioner for Health, Dr Ekem Emmanuel John, on behalf of the state government.

According to a statement by Ibom Air’s Group Manager for Marketing and Communication, Aniekan Essienette, the initiative was carried out under the airline’s Corporate Social Responsibility programme, FAMPact (Fight Against Malaria in Pregnant Women and Children Today), in commemoration of the 2026 World Malaria Day.

Essienette noted that the intervention is the third consecutive year the airline has supported malaria control efforts, reflecting its commitment to healthcare as a key CSR focus.

She added that the donation aligns with this year’s World Malaria Day theme, “Driven to end malaria, Now we can, Now we must,” and is aimed at strengthening community-level prevention and treatment, particularly for high-risk groups.

As part of activities marking the global event, Ibom Air also organised a “Walk Against Malaria” awareness campaign in Uyo on April 25. The walk commenced at Ibom Plaza and featured public sensitisation, health education, and fitness sessions.

The event also had in attendance medical influencer Dr Chinonso Egemba, popularly known as Aproko Doctor, who joined efforts to raise awareness on malaria prevention.

Malaria remains one of Nigeria’s leading public health challenges, with pregnant women and children under five among the most affected. Ibom Air said its continued interventions are designed to support government efforts to tackle the disease and improve health outcomes in affected communities.